SEC Form 4 · accession 0001127602-18-010704
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terence M Berge
Officer — VP Corp. Treasurer
Period of report
Mar 6, 2018
Accepted (ET)
Mar 8, 2018 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2018 | M | 10,000 | $19.26 | A | 30,275 | D | |
| Common Stock | Mar 6, 2018 | F | 6,499 | $61.38 | D | 23,776 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F1 | $19.26 | Mar 6, 2018 | M | 10,000 | D | — | Jun 1, 2020 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.